Getting your Trinity Audio player ready...

By Arthur Allen, KFF Health News

While the FDA is streamlining regulation of copycat versions of the expensive drugs that millions take for arthritis, cancer, and other diseases, the U.S. patent office is making it harder for the cheaper medicines to get on the market, industry officials say.

Related Articles

ICE courthouse arrests meet resistance from Democratic states

Latino US citizens racially profiled by federal immigration agents in Chicago: ‘I felt like a piece of trash’

MAHA idealism meets political reality as RFK Jr. attempts to wrangle a growing movement

Leaders arrive for a first African G20 summit overshadowed by a rift between the host and the US

Federal judge orders release of 16 migrants detained in Idaho raid, citing due

See Full Page